Rantran, Inc

RanTran, Inc. is a development-stage company based in Gainesville, FL, dedicated to investigating, developing, and commercializing therapies aimed at combating neurodegenerative diseases, which are among the most devastating health challenges today. The company focuses on groundbreaking research related to repeat-associated non-AUG (RAN) translation, striving to create innovative treatment pathways for conditions such as genetic forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Through the identification and manipulation of pathways that block RAN translation or target RAN proteins, RanTran aims to establish a platform technology that can address C9orf72-related ALS and FTD, as well as a broader range of diseases involving RAN proteins. Their commitment to scientific advancement positions them at the forefront of neurodegenerative disease research and therapy development.

Generated from the website